Okay guys, this just dawned on me and I wanted your thoughts. So Cassiopea, the company that is developing the antiandrogen Breezula (CB-06-03), is now in a Phase IIB dosing range trial. After that they will do a Phase III trial and then hopefully release it as expected in 2021. This is very...